CD56-targeted in vivo genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia
Nanoscale · 2024
DOI: 10.1039/d4nr02692f ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Avinash Chandra Kushwaha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India. subhasreerc@inst.…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Leukemia, Myeloid, Acute, Enhancer of Zeste Homolog 2 Protein, CD56 Antigen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Schematic representation of the synthesis of pEzH2@CsNPs@CD56 and its anti-AML efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India. subhasreerc@inst.ac.in.
- Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.
- Department of Clinical Hematology & Medical Oncology, Room No 18, 4th Level, F Block, Nehru Hospital, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh 160020, India.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Kushwaha, A. C., Mrunalini, B., Malhotra, P., & Roy Choudhury, S. (2024). CD56-targeted in vivo genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia. Nanoscale. https://doi.org/10.1039/d4nr02692f
Vancouver
Kushwaha AC, Mrunalini B, Malhotra P, Roy Choudhury S. CD56-targeted in vivo genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia. Nanoscale. 2024. doi:10.1039/d4nr02692f
BibTeX
@article{Kushwaha2024,
author = {Kushwaha, Avinash Chandra and Mrunalini, Boddu and Malhotra, Pankaj and Roy Choudhury, Subhasree},
title = {CD56-targeted in vivo genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia},
journal = {Nanoscale},
year = {2024},
doi = {10.1039/d4nr02692f}
}
EUVIMED